<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1'); </script>
Logo-bi
Bioimpacts. 2023;13(5): 373-382. doi: 10.34172/bi.2023.24180
PMID: 37736338        PMCID: PMC10509740

Original Article

Platinum(IV) compounds as potential drugs: a quantitative structure-activity relationship study

Jurica Novak 1,2 * ORCID, Alena R. Zykova 3 ORCID, Vladimir A. Potemkin 3 ORCID, Vladimir V. Sharutin 3, Olga K. Sharutina 3

Cited by CrossRef: 2

1- Bakalova A, Ruseva N, Cherneva E. “Non-Classical” Platinum Complexes: A Concise Review. IJMS. 2025;26(13):6270 [Crossref]
2- Momeni B, Fathi N, Biglari A, Fallahpour R, Janczak J, Puddephatt R. Structure and reactivity in reactions of dimethyltin(IV) di(azide) and di(isocyanate) with dimethylplatinum(II) complexes. Inorganica Chimica Acta. 2025;581:122613 [Crossref]
3- Novak J, Zykova A, Kumar V, Sharutin V, Sharutina O, Kumar A, AlGhamdi K, Kraljić K, Verma A. The Synthesis, in Silico Characterization and in Vitro and in Vivo Evaluation of Platinum (IV) Complexes as Potential Breast-Cancer Treatments. Biomedical Materials & Devices. 2026; [Crossref]

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons